Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2022 年第 2 季持倉
持倉截至 2022/6/30，2022/8/12 申報。只含多頭部位，變化是跟 2022 年第 1 季比股數。
- 持股檔數
- 40
- 較 2022 年第 1 季 −8
- 總值
- $1.83 億
- 較 2022 年第 1 季 −$6,958 萬 (−27.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ESTAEstablishment Labs Holdings Inc. | COM | 359,956 | $1,957 萬 | 10.7% | +185,456+106.3% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 928,256 | $1,702 萬 | 9.3% | +4,109+0.4% | 加碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 937,568 | $1,640 萬 | 9.0% | +92,413+10.9% | 加碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 222,173 | $1,511 萬 | 8.3% | +2,173+1.0% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 125,087 | $1,163 萬 | 6.4% | +5,087+4.2% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $1,090 萬 | 6.0% | – | – | – |
| LNTHLantheus Holdings, Inc. | Stock | 140,000 | $924.4 萬 | 5.1% | +25,000+21.7% | 加碼 | 歷史 |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $801.9 萬 | 4.4% | – | – | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $715.8 萬 | 3.9% | +25,000+33.3% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 75,000 | $598.2 萬 | 3.3% | +45,000+150.0% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 45,000 | $569.3 萬 | 3.1% | +37,500+500.0% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 85,000 | $561.6 萬 | 3.1% | −75,000−46.9% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 215,723 | $468.1 萬 | 2.6% | −249,931−53.7% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 493,278 | $455.8 萬 | 2.5% | −106,722−17.8% | 減碼 | – |
| RPTXRepare Therapeutics Inc. | COM | 321,200 | $449.4 萬 | 2.5% | −147,705−31.5% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $423.7 萬 | 2.3% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $415.4 萬 | 2.3% | – | – | – |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,372,244 | $404.8 萬 | 2.2% | +100,000+7.9% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 250,466 | $344.6 萬 | 1.9% | −49,534−16.5% | 減碼 | 歷史 |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 352,500 | $342.6 萬 | 1.9% | −350,000−49.8% | 減碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 70,000 | $196.7 萬 | 1.1% | −137,500−66.3% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 883,654 | $187.3 萬 | 1.0% | +106,044+13.6% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,374,098 | $181.4 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 100,000 | $139.6 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 75,000 | $135.6 萬 | 0.7% | +75,000 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 466,607 | $125.5 萬 | 0.7% | −92,412−16.5% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 125,000 | $112.8 萬 | 0.6% | +125,000 | 新進 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 40,000 | $107.8 萬 | 0.6% | −85,000−68.0% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 401,268 | $99.5 萬 | 0.5% | +401,268 | 新進 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 450,000 | $97.2 萬 | 0.5% | +125,000+38.5% | 加碼 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 170,000 | $72.1 萬 | 0.4% | +170,000 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 15,000 | $58.9 萬 | 0.3% | +15,000 | 新進 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 279,775 | $56.2 萬 | 0.3% | +58,393+26.4% | 加碼 | 歷史 |
| RCORRenovacor, Inc. | COM | 199,490 | $40.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $38.2 萬 | 0.2% | 00.0% | 不變 | – |
| CRISCuris Inc | COM NEW | 340,349 | $33.5 萬 | 0.2% | −9,651−2.8% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 20,660 | $23.9 萬 | 0.1% | −29,340−58.7% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 25,578 | $17.4 萬 | 0.1% | +25,578 | 新進 | 歷史 |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $8,000 | <0.1% | 00.0% | 不變 | – |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $5,000 | <0.1% | 00.0% | 不變 | – |
選擇權（13 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| LLYEli Lilly & Co | Stock | – | $972.7 萬 |
| NVAXNovavax Inc | COM NEW | $462.9 萬 | $437.2 萬 |
| ESTAEstablishment Labs Holdings Inc. | COM | $815.7 萬 | – |
| KRTXKaruna Therapeutics, Inc. | COM | $569.3 萬 | – |
| LNTHLantheus Holdings, Inc. | Stock | $462.2 萬 | – |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $425.4 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | – | $390.9 萬 |
| LEGNLegend Biotech Corp | SPONSORED ADS | – | $275.0 萬 |
| MRNAModerna, Inc. | Stock | – | $214.3 萬 |
| FATEFate Therapeutics Inc | COM | – | $167.3 萬 |
| IOVAIovance Biotherapeutics, Inc. | COM | – | $165.6 萬 |
| CELUCelularity Inc | COM CL A | $62.4 萬 | – |
| LNAILunai Bioworks Inc. | COM | $38.6 萬 | – |
2022 年第 1 季之後清倉（14 檔）
2022 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 1 季股數 | 2022 年第 1 季市值 | 2022 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 247,000 | $1,394 萬 | 5.5% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 300,000 | $710.4 萬 | 2.8% | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 171,592 | $596.3 萬 | 2.4% | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $297.3 萬 | 1.2% | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $293.4 萬 | 1.2% | – |
| TVTXTravere Therapeutics, Inc. | COM | 100,000 | $257.7 萬 | 1.0% | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 70,000 | $245.1 萬 | 1.0% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 80,000 | $244.6 萬 | 1.0% | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 70,000 | $242.5 萬 | 1.0% | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 400,000 | $122.0 萬 | 0.5% | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 65,282 | $58.6 萬 | 0.2% | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 1,000,000 | $40.4 萬 | 0.2% | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 76,162 | $27.0 萬 | 0.1% | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 1,988 | $12.7 萬 | 0.1% | 歷史 |